Luisa Fernanda Briones Márquez

Dr. Luisa Fernanda Briones Márquez

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2023 in Heliyon
Verified
Journal Article
Open access
LMLuisa Fernanda Briones Márquez
Luisa Fernanda Briones Márquez
JNJosé Navarro-Partida
José Navarro-Partida
AHAzucena Herrera-González
Azucena Herrera-González
MGMiguel A. García-Bon
Miguel A. García-Bon
IMIliany Annel Martínez-Álvarez
Iliany Annel Martínez-Álvarez
ELEdgar J López-Naranjo
Edgar J López-Naranjo
This paper evaluates the potential of a microwave radiation (MR) assisted method as an active drug loading technique for exosomes using polyphenolic nutraceuticals as model drugs (i.e. resveratrol (RV), rosmarinic acid (RA), pterostilbene (PT) and epigallocatechin gallate (EG)). MR is evaluated as a single step method and as part of a two-step method consisting of incubation (IN) followed by MR. The effect of exposure time, loading method and type of nutraceutical on the loading efficiency were investigated using high performance liquid chromatography (HPLC), X-ray diffraction (XRD) and flow cytometry. Additionally, dynamic light scattering (DLS) was used to determine the size of exosomes. Loading efficiency results indicated that MR is a promising method to be used as loading process. Results also suggested that due to different levels of hydrophobicity, related to the number of OH groups, the absorption of polyphenols into the bilayer of EVs is different for each molecule. According to XRD results, MR could not be used with any cargo drug since radiation could affect the chemical composition and the degree of crystallinity of such molecules, consequently affecting their performance. Flow cytometry results indicated that loading methods negatively affect exosome concentration.

29 November 2025 in Molecules
Verified
Journal Article
Open access
PDF file
ELEdgar J López-Naranjo
Edgar J López-Naranjo
Margarita Cid HernándezMargarita Cid Hernández
Margarita Cid Hernández
Milton VazquezMilton Vazquez
Milton Vazquez
MGMarisol Luviano García
Marisol Luviano García
MPM. Judith Sanchez Peña
M. Judith Sanchez Peña
Azucena Herrera-GonzálezAzucena Herrera-González
Azucena Herrera-González
This work reports the biosynthesis of silver nanoparticles (AgNPs) using an autoclave method with Tagetes erecta extract (TEE) as a source of reducing agents, silver nitrate (AgNO3) as the metal precursor, and a nucleating agent (i.e., sodium chloride [S]) or a structure director agent (i.e., gum Arabic [G] or hydrous magnesium silicate/talc powder [T]) to tailor the morphology of AgNPs. Since the properties and potential applications of AgNPs depend on their size and shape, these additives were employed to achieve morphological control. Phytochemical screening tests and UPCL-Qtof-MS/MS profiling of TEE were performed to identify the compounds present in the extract, indicating that highly polar phenolic compounds such as saponins, tannins, and flavonoids are present in TEE, allowing it to act as a source of reducing/stabilizing agents. The biosynthesized AgNPs exhibited different morphologies (i.e., spheres, rods, ribbons, and wires) depending on the modifying agent used (i.e., S, G, or T). Characterization techniques including scanning electron microscopy (SEM), transmission electron microscopy (TEM), ultraviolet–visible spectroscopy (UV–vis), and X-ray diffraction (XRD) confirmed the successful use of S, G, and T in modulating AgNP morphology. The results of the antibacterial activity evaluation demonstrated that both TEE and AgNPs possess bacteriostatic activity against Escherichia coli and Enterococcus faecalis, with the use of S as a nucleating agent increasing the inhibitory effect of AgNPs.

20 June 2025 in Molecules
Verified
Journal Article
Open access
PDF file
GSGerardo León Sánchez
Gerardo León Sánchez
EGEulogio Orozco Guareño
Eulogio Orozco Guareño
OZOscar Guillermo Zúñiga-González
Oscar Guillermo Zúñiga-González
LMLuisa Fernanda Briones Márquez
Luisa Fernanda Briones Márquez
RQRaúl R. Quiñonez-López
Raúl R. Quiñonez-López
MSMARIA DE JESÚS PALACIOS SANCHEZ
MARIA DE JESÚS PALACIOS SANCHEZ
Polymeric nanoparticles based on poly(ethyl cyanoacrylate) (PECA) and poly(ε-caprolactone) (PCL) were synthesized via semicontinuous microemulsion polymerization for potential biomedical applications. A systematic evaluation of four surfactants (Tween 80, Alkonat L70, Genapol LRO, and Brij-20) was carried out to determine their effects on micelle formation and particle size. Brij-20 enabled the formation of nanoparticles under 100 nm, with optimal conditions identified at 4% surfactant concentration and pH 1.75. The polymerization process included acid-catalyzed ring-opening of ε-caprolactone, followed by the semicontinuous addition of ethyl-2-cyanoacrylate under an inert atmosphere. Copolymerization was confirmed through FT-IR spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and differential scanning calorimetry, revealing a glass transition temperature (Tg) of 110.9 °C, indicating PECA as the dominant phase. Thermogravimetric analysis showed two decomposition events corresponding to each polymer. Transmission electron microscope analysis revealed nanoparticles averaging 51.74 nm in diameter. These findings demonstrate the feasibility of producing PECA-PCL nanoparticles with controlled size and composition, suitable for drug delivery and other biomedical uses.

11 September 2026 in Cosmetics
Verified
Journal Article
Open access
PDF file
JAJosé de Jesús Rodríguez Aleriano
José de Jesús Rodríguez Aleriano
OCOdessa Magallon Chavez
Odessa Magallon Chavez
JNJOSE NAVARRO
JOSE NAVARRO
LMLuisa Fernanda Briones Márquez
Luisa Fernanda Briones Márquez
ELEdgar J López-Naranjo
Edgar J López-Naranjo
JLJuan Antonio Rivas Loaiza
Juan Antonio Rivas Loaiza
Polydeoxyribonucleotide (PDRN) has emerged as a promising bioactive biomaterial with broad applications in regenerative medicine because of its anti-inflammatory, angiogenic, and tissue-repair properties. Traditionally obtained from salmonid sperm DNA, it has been reported to promote tissue regeneration primarily by activating adenosine A2A receptors and the nucleotide salvage pathway, thereby stimulating fibroblast proliferation, extracellular matrix remodeling, collagen synthesis, and angiogenesis. This review provides a comprehensive overview of the biochemical characteristics, mechanisms of action, extraction methods, and translational potential of PDRN from different biological sources. In addition to conventional animal-derived PDRN, recent advances have introduced plant-derived (PhytoPDRN) and microbial- or algae-derived alternatives, offering improved sustainability, scalability, and reduced environmental impact. Preliminary in vitro evidence suggests that these emerging sources may exhibit regenerative and antioxidant activities; however, differences in molecular characteristics, experimental models, and study designs currently preclude establishing biological or clinical equivalence with salmon-derived PDRN. Finally, the translational perspectives, industrial challenges, and future research directions are analyzed, highlighting the need for standardized manufacturing processes, comparative clinical trials, and sustainable production strategies. Overall, PDRN is a DNA-derived biomaterial of growing interest in regenerative medicine and cosmetic applications. At the same time, novel biological sources may contribute to the development of more sustainable and clinically effective next-generation PDRN-based therapies.